Do liver IL-12 levels predict sustained response to IFN-alpha therapy in children with chronic hepatitis B?
Ozkan
Tanju B
TB
Department of Pediatric Gastroenterology, Hepatology and Nutrition, Uludag University Faculty of Medicine, Bursa, Turkey. ozkant@uludag.edu.tr
Budak
Ferah
F
Erdemir
Gulin
G
Ozgur
Taner
T
Aker
Sibel
S
D000293:Adolescent; D002648:Child; D004279:DNA, Viral / Q000097:blood; D005260:Female; D006515:Hepatitis B virus / Q000472:pathogenicity / Q000502:physiology*; D019694:Hepatitis B, Chronic / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy / Q000276:immunology; D006801:Humans; D007167:Immunotherapy; D007279:Injections, Subcutaneous; D016898:Interferon-alpha / Q000008:administration & dosage* / Q000627:therapeutic use; D007371:Interferon-gamma / Q000097:blood / Q000276:immunology; D018664:Interleukin-12 / Q000276:immunology / Q000378:metabolism*; D008099:Liver / Q000276:immunology / Q000378:metabolism* / Q000821:virology; D008297:Male; D011379:Prognosis; D011446:Prospective Studies; D016896:Treatment Outcome; D014779:Virus Replication / Q000187:drug effects / Q000276:immunology
D004279:DNA, Viral; D016898:Interferon-alpha; D018664:Interleukin-12; D007371:Interferon-gamma